SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) Fundamental Analysis & Valuation

ELI:SLBEN • PTSLB0AM0010

Current stock price

6.76 EUR
+0.2 (+3.05%)
Last:

This SLBEN.LS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. SLBEN.LS Profitability Analysis

1.1 Basic Checks

  • SLBEN had positive earnings in the past year.
  • SLBEN had a negative operating cash flow in the past year.
  • In multiple years SLBEN reported negative net income over the last 5 years.
  • In the past 5 years SLBEN always reported negative operating cash flow.
SLBEN.LS Yearly Net Income VS EBIT VS OCF VS FCFSLBEN.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.17%, SLBEN belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
  • With an excellent Return On Equity value of 22.13%, SLBEN belongs to the best of the industry, outperforming 84.09% of the companies in the same industry.
  • The Return On Invested Capital of SLBEN (9.68%) is better than 77.27% of its industry peers.
Industry RankSector Rank
ROA 5.17%
ROE 22.13%
ROIC 9.68%
ROA(3y)0.34%
ROA(5y)-1.77%
ROE(3y)-1.66%
ROE(5y)-9.84%
ROIC(3y)N/A
ROIC(5y)N/A
SLBEN.LS Yearly ROA, ROE, ROICSLBEN.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

1.3 Margins

  • Looking at the Profit Margin, with a value of 14.98%, SLBEN belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
  • SLBEN's Profit Margin has declined in the last couple of years.
  • With an excellent Operating Margin value of 21.36%, SLBEN belongs to the best of the industry, outperforming 93.18% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SLBEN has declined.
  • SLBEN's Gross Margin of 65.88% is in line compared to the rest of the industry. SLBEN outperforms 59.09% of its industry peers.
  • SLBEN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 21.36%
PM (TTM) 14.98%
GM 65.88%
OM growth 3YN/A
OM growth 5Y-11.5%
PM growth 3YN/A
PM growth 5Y-12.9%
GM growth 3Y3.32%
GM growth 5Y6.61%
SLBEN.LS Yearly Profit, Operating, Gross MarginsSLBEN.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. SLBEN.LS Health Analysis

2.1 Basic Checks

  • SLBEN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for SLBEN remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, SLBEN has about the same amount of shares outstanding.
  • Compared to 1 year ago, SLBEN has an improved debt to assets ratio.
SLBEN.LS Yearly Shares OutstandingSLBEN.LS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
SLBEN.LS Yearly Total Debt VS Total AssetsSLBEN.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of 0.51, we must say that SLBEN is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.51, SLBEN is not doing good in the industry: 61.36% of the companies in the same industry are doing better.
  • SLBEN has a Debt/Equity ratio of 0.95. This is a neutral value indicating SLBEN is somewhat dependend on debt financing.
  • SLBEN has a Debt to Equity ratio (0.95) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Altman-Z 0.51
ROIC/WACC1.49
WACC6.49%
SLBEN.LS Yearly LT Debt VS Equity VS FCFSLBEN.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 0.39 indicates that SLBEN may have some problems paying its short term obligations.
  • SLBEN's Current ratio of 0.39 is on the low side compared to the rest of the industry. SLBEN is outperformed by 81.82% of its industry peers.
  • SLBEN has a Quick Ratio of 0.39. This is a bad value and indicates that SLBEN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.39, SLBEN is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.39
SLBEN.LS Yearly Current Assets VS Current LiabilitesSLBEN.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SLBEN.LS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 483.32% over the past year.
  • SLBEN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.75% yearly.
  • The Revenue has grown by 29.98% in the past year. This is a very strong growth!
  • The Revenue has been growing by 10.50% on average over the past years. This is quite good.
EPS 1Y (TTM)483.32%
EPS 3YN/A
EPS 5Y-3.75%
EPS Q2Q%0.7%
Revenue 1Y (TTM)29.98%
Revenue growth 3Y10.84%
Revenue growth 5Y10.5%
Sales Q2Q%1.1%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SLBEN.LS Yearly Revenue VS EstimatesSLBEN.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

Find the best growth stocksShow best growing peers

2

4. SLBEN.LS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 4.48 indicates a rather cheap valuation of SLBEN.
  • Based on the Price/Earnings ratio, SLBEN is valued cheaper than 97.73% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.23. SLBEN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.48
Fwd PE N/A
SLBEN.LS Price Earnings VS Forward Price EarningsSLBEN.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLBEN.LS Per share dataSLBEN.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SLBEN.LS Dividend Analysis

5.1 Amount

  • SLBEN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SLBEN.LS Fundamentals: All Metrics, Ratios and Statistics

SPORT LISBOA E BENFICA-FUT S

ELI:SLBEN (3/20/2026, 7:00:00 PM)

6.76

+0.2 (+3.05%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners19.7%
Ins Owner ChangeN/A
Market Cap155.48M
Revenue(TTM)231.78M
Net Income(TTM)34.73M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.48
Fwd PE N/A
P/S 0.67
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB N/A
EV/EBITDA N/A
EPS(TTM)1.51
EY22.34%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-5.36
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS10.08
BVpS6.82
TBVpS-3.67
PEG (NY)N/A
PEG (5Y)N/A
Graham Number15.23
Profitability
Industry RankSector Rank
ROA 5.17%
ROE 22.13%
ROCE 13.79%
ROIC 9.68%
ROICexc 9.91%
ROICexgc 25.51%
OM 21.36%
PM (TTM) 14.98%
GM 65.88%
FCFM N/A
ROA(3y)0.34%
ROA(5y)-1.77%
ROE(3y)-1.66%
ROE(5y)-9.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y3.6%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.68%
OM growth 3YN/A
OM growth 5Y-11.5%
PM growth 3YN/A
PM growth 5Y-12.9%
GM growth 3Y3.32%
GM growth 5Y6.61%
F-Score6
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 49.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.39
Altman-Z 0.51
F-Score6
WACC6.49%
ROIC/WACC1.49
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)45.58%
Cap/Sales(5y)48.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)483.32%
EPS 3YN/A
EPS 5Y-3.75%
EPS Q2Q%0.7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.98%
Revenue growth 3Y10.84%
Revenue growth 5Y10.5%
Sales Q2Q%1.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y502.06%
EBIT growth 3YN/A
EBIT growth 5Y-2.21%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.95%
OCF growth 3YN/A
OCF growth 5YN/A

SPORT LISBOA E BENFICA-FUT S / SLBEN.LS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to SLBEN.LS.


Can you provide the valuation status for SPORT LISBOA E BENFICA-FUT S?

ChartMill assigns a valuation rating of 0 / 10 to SPORT LISBOA E BENFICA-FUT S (SLBEN.LS). This can be considered as Overvalued.


Can you provide the profitability details for SPORT LISBOA E BENFICA-FUT S?

SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for SLBEN stock?

The Price/Earnings (PE) ratio for SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) is 4.48 and the Price/Book (PB) ratio is 0.99.